世界のテストステロンホルモン薬市場インサイト・予測（～2027年）

• 英文タイトル：Global Testosterone Hormone Drug Market Insights and Forecast to 2027

• レポートコード：QY2108PAL4045
• 出版社/出版日：QYResearch / 2021年8月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、110ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査資料はテストステロンホルモン薬の世界市場の現状について調査・分析し、2027年までの市場を予測しました。テストステロンホルモン薬の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（ジェル、注射、パッチ）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。

・テストステロンホルモン薬の世界市場概要
・メーカー別の競争状況、市場シェア
・テストステロンホルモン薬の種類別市場規模：ジェル、注射、パッチ
・テストステロンホルモン薬の用途別市場規模：病院、クリニック、その他
・北米のテストステロンホルモン薬市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ）
・ヨーロッパのテストステロンホルモン薬市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス）
・アジアのテストステロンホルモン薬市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国）
・中南米のテストステロンホルモン薬市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル）
・中東・アフリカのテストステロンホルモン薬市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア）
・企業情報：AbbVie、Endo International、Eli lilly、Pfizer、Actavis (Allergan)、Bayer、Novartis、Teva、Mylan、Upsher-Smith、Ferring Pharmaceuticals、Kyowa Kirin、Acerus Pharmaceuticals
・テストステロンホルモン薬のバリューチェーン・販売チャネル分析
・テストステロンホルモン薬の世界市場動向

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

Market Analysis and Insights: Global Testosterone Hormone Drug Market
The global Testosterone Hormone Drug market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Testosterone Hormone Drug Scope and Segment
Testosterone Hormone Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Testosterone Hormone Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Gels
Injections
Patches

Segment by Application
Hospitals
Clinics
Others

By Company
AbbVie
Endo International
Eli lilly
Pfizer
Actavis (Allergan)
Bayer
Novartis
Teva
Mylan
Upsher-Smith
Ferring Pharmaceuticals
Kyowa Kirin
Acerus Pharmaceuticals

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Testosterone Hormone Drug Product Introduction
1.2 Market by Type
1.2.1 Global Testosterone Hormone Drug Market Size Growth Rate by Type
1.2.2 Gels
1.2.3 Injections
1.2.4 Patches
1.3 Market by Application
1.3.1 Global Testosterone Hormone Drug Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Testosterone Hormone Drug Sales Estimates and Forecasts 2016-2027
2.2 Global Testosterone Hormone Drug Revenue Estimates and Forecasts 2016-2027
2.3 Global Testosterone Hormone Drug Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Testosterone Hormone Drug Regions by Sales
2.4.1 Global Top Testosterone Hormone Drug Regions by Sales (2016-2021)
2.4.2 Global Top Testosterone Hormone Drug Regions by Sales (2022-2027)
2.5 Global Top Testosterone Hormone Drug Regions by Revenue
2.5.1 Global Top Testosterone Hormone Drug Regions by Revenue (2016-2021)
2.5.2 Global Top Testosterone Hormone Drug Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Testosterone Hormone Drug Sales by Manufacturers
3.1.1 Global Top Testosterone Hormone Drug Manufacturers by Sales (2016-2021)
3.1.2 Global Top Testosterone Hormone Drug Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Testosterone Hormone Drug Sales in 2020
3.2 Global Testosterone Hormone Drug Revenue by Manufacturers
3.2.1 Global Top Testosterone Hormone Drug Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Testosterone Hormone Drug Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Testosterone Hormone Drug Revenue in 2020
3.3 Global Testosterone Hormone Drug Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Testosterone Hormone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Testosterone Hormone Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Testosterone Hormone Drug Sales by Type
4.1.1 Global Testosterone Hormone Drug Historical Sales by Type (2016-2021)
4.1.2 Global Testosterone Hormone Drug Forecasted Sales by Type (2022-2027)
4.1.3 Global Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
4.2 Global Testosterone Hormone Drug Revenue by Type
4.2.1 Global Testosterone Hormone Drug Historical Revenue by Type (2016-2021)
4.2.2 Global Testosterone Hormone Drug Forecasted Revenue by Type (2022-2027)
4.2.3 Global Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
4.3 Global Testosterone Hormone Drug Price by Type
4.3.1 Global Testosterone Hormone Drug Price by Type (2016-2021)
4.3.2 Global Testosterone Hormone Drug Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Testosterone Hormone Drug Sales by Application
5.1.1 Global Testosterone Hormone Drug Historical Sales by Application (2016-2021)
5.1.2 Global Testosterone Hormone Drug Forecasted Sales by Application (2022-2027)
5.1.3 Global Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
5.2 Global Testosterone Hormone Drug Revenue by Application
5.2.1 Global Testosterone Hormone Drug Historical Revenue by Application (2016-2021)
5.2.2 Global Testosterone Hormone Drug Forecasted Revenue by Application (2022-2027)
5.2.3 Global Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
5.3 Global Testosterone Hormone Drug Price by Application
5.3.1 Global Testosterone Hormone Drug Price by Application (2016-2021)
5.3.2 Global Testosterone Hormone Drug Price Forecast by Application (2022-2027)

6 North America
6.1 North America Testosterone Hormone Drug Market Size by Type
6.1.1 North America Testosterone Hormone Drug Sales by Type (2016-2027)
6.1.2 North America Testosterone Hormone Drug Revenue by Type (2016-2027)
6.2 North America Testosterone Hormone Drug Market Size by Application
6.2.1 North America Testosterone Hormone Drug Sales by Application (2016-2027)
6.2.2 North America Testosterone Hormone Drug Revenue by Application (2016-2027)
6.3 North America Testosterone Hormone Drug Market Size by Country
6.3.1 North America Testosterone Hormone Drug Sales by Country (2016-2027)
6.3.2 North America Testosterone Hormone Drug Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Testosterone Hormone Drug Market Size by Type
7.1.1 Europe Testosterone Hormone Drug Sales by Type (2016-2027)
7.1.2 Europe Testosterone Hormone Drug Revenue by Type (2016-2027)
7.2 Europe Testosterone Hormone Drug Market Size by Application
7.2.1 Europe Testosterone Hormone Drug Sales by Application (2016-2027)
7.2.2 Europe Testosterone Hormone Drug Revenue by Application (2016-2027)
7.3 Europe Testosterone Hormone Drug Market Size by Country
7.3.1 Europe Testosterone Hormone Drug Sales by Country (2016-2027)
7.3.2 Europe Testosterone Hormone Drug Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Testosterone Hormone Drug Market Size by Type
8.1.1 Asia Pacific Testosterone Hormone Drug Sales by Type (2016-2027)
8.1.2 Asia Pacific Testosterone Hormone Drug Revenue by Type (2016-2027)
8.2 Asia Pacific Testosterone Hormone Drug Market Size by Application
8.2.1 Asia Pacific Testosterone Hormone Drug Sales by Application (2016-2027)
8.2.2 Asia Pacific Testosterone Hormone Drug Revenue by Application (2016-2027)
8.3 Asia Pacific Testosterone Hormone Drug Market Size by Region
8.3.1 Asia Pacific Testosterone Hormone Drug Sales by Region (2016-2027)
8.3.2 Asia Pacific Testosterone Hormone Drug Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Testosterone Hormone Drug Market Size by Type
9.1.1 Latin America Testosterone Hormone Drug Sales by Type (2016-2027)
9.1.2 Latin America Testosterone Hormone Drug Revenue by Type (2016-2027)
9.2 Latin America Testosterone Hormone Drug Market Size by Application
9.2.1 Latin America Testosterone Hormone Drug Sales by Application (2016-2027)
9.2.2 Latin America Testosterone Hormone Drug Revenue by Application (2016-2027)
9.3 Latin America Testosterone Hormone Drug Market Size by Country
9.3.1 Latin America Testosterone Hormone Drug Sales by Country (2016-2027)
9.3.2 Latin America Testosterone Hormone Drug Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Testosterone Hormone Drug Market Size by Type
10.1.1 Middle East and Africa Testosterone Hormone Drug Sales by Type (2016-2027)
10.1.2 Middle East and Africa Testosterone Hormone Drug Revenue by Type (2016-2027)
10.2 Middle East and Africa Testosterone Hormone Drug Market Size by Application
10.2.1 Middle East and Africa Testosterone Hormone Drug Sales by Application (2016-2027)
10.2.2 Middle East and Africa Testosterone Hormone Drug Revenue by Application (2016-2027)
10.3 Middle East and Africa Testosterone Hormone Drug Market Size by Country
10.3.1 Middle East and Africa Testosterone Hormone Drug Sales by Country (2016-2027)
10.3.2 Middle East and Africa Testosterone Hormone Drug Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Overview
11.1.3 AbbVie Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 AbbVie Testosterone Hormone Drug Product Description
11.1.5 AbbVie Recent Developments
11.2 Endo International
11.2.1 Endo International Corporation Information
11.2.2 Endo International Overview
11.2.3 Endo International Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Endo International Testosterone Hormone Drug Product Description
11.2.5 Endo International Recent Developments
11.3 Eli lilly
11.3.1 Eli lilly Corporation Information
11.3.2 Eli lilly Overview
11.3.3 Eli lilly Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Eli lilly Testosterone Hormone Drug Product Description
11.3.5 Eli lilly Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Pfizer Testosterone Hormone Drug Product Description
11.4.5 Pfizer Recent Developments
11.5 Actavis (Allergan)
11.5.1 Actavis (Allergan) Corporation Information
11.5.2 Actavis (Allergan) Overview
11.5.3 Actavis (Allergan) Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Actavis (Allergan) Testosterone Hormone Drug Product Description
11.5.5 Actavis (Allergan) Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Bayer Testosterone Hormone Drug Product Description
11.6.5 Bayer Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Overview
11.7.3 Novartis Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Novartis Testosterone Hormone Drug Product Description
11.7.5 Novartis Recent Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Overview
11.8.3 Teva Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Teva Testosterone Hormone Drug Product Description
11.8.5 Teva Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Overview
11.9.3 Mylan Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Mylan Testosterone Hormone Drug Product Description
11.9.5 Mylan Recent Developments
11.10 Upsher-Smith
11.10.1 Upsher-Smith Corporation Information
11.10.2 Upsher-Smith Overview
11.10.3 Upsher-Smith Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Upsher-Smith Testosterone Hormone Drug Product Description
11.10.5 Upsher-Smith Recent Developments
11.11 Ferring Pharmaceuticals
11.11.1 Ferring Pharmaceuticals Corporation Information
11.11.2 Ferring Pharmaceuticals Overview
11.11.3 Ferring Pharmaceuticals Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.11.4 Ferring Pharmaceuticals Testosterone Hormone Drug Product Description
11.11.5 Ferring Pharmaceuticals Recent Developments
11.12 Kyowa Kirin
11.12.1 Kyowa Kirin Corporation Information
11.12.2 Kyowa Kirin Overview
11.12.3 Kyowa Kirin Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 Kyowa Kirin Testosterone Hormone Drug Product Description
11.12.5 Kyowa Kirin Recent Developments
11.13 Acerus Pharmaceuticals
11.13.1 Acerus Pharmaceuticals Corporation Information
11.13.2 Acerus Pharmaceuticals Overview
11.13.3 Acerus Pharmaceuticals Testosterone Hormone Drug Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Acerus Pharmaceuticals Testosterone Hormone Drug Product Description
11.13.5 Acerus Pharmaceuticals Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Testosterone Hormone Drug Value Chain Analysis
12.2 Testosterone Hormone Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Testosterone Hormone Drug Production Mode & Process
12.4 Testosterone Hormone Drug Sales and Marketing
12.4.1 Testosterone Hormone Drug Sales Channels
12.4.2 Testosterone Hormone Drug Distributors
12.5 Testosterone Hormone Drug Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Testosterone Hormone Drug Industry Trends
13.2 Testosterone Hormone Drug Market Drivers
13.3 Testosterone Hormone Drug Market Challenges
13.4 Testosterone Hormone Drug Market Restraints

14 Key Findings in The Global Testosterone Hormone Drug Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Testosterone Hormone Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Gels
Table 3. Major Manufacturers of Injections
Table 4. Major Manufacturers of Patches
Table 5. Global Testosterone Hormone Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Testosterone Hormone Drug Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 7. Global Testosterone Hormone Drug Sales by Region (2016-2021) & (K Units)
Table 8. Global Testosterone Hormone Drug Sales Market Share by Region (2016-2021)
Table 9. Global Testosterone Hormone Drug Sales by Region (2022-2027) & (K Units)
Table 10. Global Testosterone Hormone Drug Sales Market Share by Region (2022-2027)
Table 11. Global Testosterone Hormone Drug Revenue by Region (2016-2021) & (US$ Million)
Table 12. Global Testosterone Hormone Drug Revenue Market Share by Region (2016-2021)
Table 13. Global Testosterone Hormone Drug Revenue by Region (2022-2027) & (US$ Million)
Table 14. Global Testosterone Hormone Drug Revenue Market Share by Region (2022-2027)
Table 15. Global Testosterone Hormone Drug Sales by Manufacturers (2016-2021) & (K Units)
Table 16. Global Testosterone Hormone Drug Sales Share by Manufacturers (2016-2021)
Table 17. Global Testosterone Hormone Drug Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 18. Global Testosterone Hormone Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Testosterone Hormone Drug Price by Manufacturers 2016-2021 (US$/Unit)
Table 20. Global Testosterone Hormone Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Testosterone Hormone Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Testosterone Hormone Drug as of 2020)
Table 22. Testosterone Hormone Drug Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Testosterone Hormone Drug Product Offered
Table 24. Date of Manufacturers Enter into Testosterone Hormone Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 27. Global Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 28. Global Testosterone Hormone Drug Sales Share by Type (2016-2021)
Table 29. Global Testosterone Hormone Drug Sales Share by Type (2022-2027)
Table 30. Global Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 31. Global Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 32. Global Testosterone Hormone Drug Revenue Share by Type (2016-2021)
Table 33. Global Testosterone Hormone Drug Revenue Share by Type (2022-2027)
Table 34. Testosterone Hormone Drug Price by Type (2016-2021) & (US$/Unit)
Table 35. Global Testosterone Hormone Drug Price Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 37. Global Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 38. Global Testosterone Hormone Drug Sales Share by Application (2016-2021)
Table 39. Global Testosterone Hormone Drug Sales Share by Application (2022-2027)
Table 40. Global Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 41. Global Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 42. Global Testosterone Hormone Drug Revenue Share by Application (2016-2021)
Table 43. Global Testosterone Hormone Drug Revenue Share by Application (2022-2027)
Table 44. Testosterone Hormone Drug Price by Application (2016-2021) & (US$/Unit)
Table 45. Global Testosterone Hormone Drug Price Forecast by Application (2022-2027) & (US$/Unit)
Table 46. North America Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 47. North America Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 48. North America Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 49. North America Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 50. North America Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 51. North America Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 52. North America Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 53. North America Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 54. North America Testosterone Hormone Drug Sales by Country (2016-2021) & (K Units)
Table 55. North America Testosterone Hormone Drug Sales by Country (2022-2027) & (K Units)
Table 56. North America Testosterone Hormone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 57. North America Testosterone Hormone Drug Revenue by Country (2022-2027) & (US$ Million)
Table 58. Europe Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 59. Europe Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 60. Europe Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 61. Europe Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 62. Europe Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 63. Europe Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 64. Europe Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 65. Europe Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 66. Europe Testosterone Hormone Drug Sales by Country (2016-2021) & (K Units)
Table 67. Europe Testosterone Hormone Drug Sales by Country (2022-2027) & (K Units)
Table 68. Europe Testosterone Hormone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 69. Europe Testosterone Hormone Drug Revenue by Country (2022-2027) & (US$ Million)
Table 70. Asia Pacific Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 71. Asia Pacific Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 72. Asia Pacific Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 73. Asia Pacific Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 74. Asia Pacific Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 75. Asia Pacific Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 76. Asia Pacific Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 77. Asia Pacific Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 78. Asia Pacific Testosterone Hormone Drug Sales by Region (2016-2021) & (K Units)
Table 79. Asia Pacific Testosterone Hormone Drug Sales by Region (2022-2027) & (K Units)
Table 80. Asia Pacific Testosterone Hormone Drug Revenue by Region (2016-2021) & (US$ Million)
Table 81. Asia Pacific Testosterone Hormone Drug Revenue by Region (2022-2027) & (US$ Million)
Table 82. Latin America Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 83. Latin America Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 84. Latin America Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 85. Latin America Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 86. Latin America Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 87. Latin America Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 88. Latin America Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 89. Latin America Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 90. Latin America Testosterone Hormone Drug Sales by Country (2016-2021) & (K Units)
Table 91. Latin America Testosterone Hormone Drug Sales by Country (2022-2027) & (K Units)
Table 92. Latin America Testosterone Hormone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 93. Latin America Testosterone Hormone Drug Revenue by Country (2022-2027) & (US$ Million)
Table 94. Middle East and Africa Testosterone Hormone Drug Sales by Type (2016-2021) & (K Units)
Table 95. Middle East and Africa Testosterone Hormone Drug Sales by Type (2022-2027) & (K Units)
Table 96. Middle East and Africa Testosterone Hormone Drug Revenue by Type (2016-2021) & (US$ Million)
Table 97. Middle East and Africa Testosterone Hormone Drug Revenue by Type (2022-2027) & (US$ Million)
Table 98. Middle East and Africa Testosterone Hormone Drug Sales by Application (2016-2021) & (K Units)
Table 99. Middle East and Africa Testosterone Hormone Drug Sales by Application (2022-2027) & (K Units)
Table 100. Middle East and Africa Testosterone Hormone Drug Revenue by Application (2016-2021) & (US$ Million)
Table 101. Middle East and Africa Testosterone Hormone Drug Revenue by Application (2022-2027) & (US$ Million)
Table 102. Middle East and Africa Testosterone Hormone Drug Sales by Country (2016-2021) & (K Units)
Table 103. Middle East and Africa Testosterone Hormone Drug Sales by Country (2022-2027) & (K Units)
Table 104. Middle East and Africa Testosterone Hormone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 105. Middle East and Africa Testosterone Hormone Drug Revenue by Country (2022-2027) & (US$ Million)
Table 106. AbbVie Corporation Information
Table 107. AbbVie Description and Major Businesses
Table 108. AbbVie Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 109. AbbVie Testosterone Hormone Drug Product
Table 110. AbbVie Recent Developments
Table 111. Endo International Corporation Information
Table 112. Endo International Description and Major Businesses
Table 113. Endo International Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 114. Endo International Testosterone Hormone Drug Product
Table 115. Endo International Recent Developments
Table 116. Eli lilly Corporation Information
Table 117. Eli lilly Description and Major Businesses
Table 118. Eli lilly Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 119. Eli lilly Testosterone Hormone Drug Product
Table 120. Eli lilly Recent Developments
Table 121. Pfizer Corporation Information
Table 122. Pfizer Description and Major Businesses
Table 123. Pfizer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 124. Pfizer Testosterone Hormone Drug Product
Table 125. Pfizer Recent Developments
Table 126. Actavis (Allergan) Corporation Information
Table 127. Actavis (Allergan) Description and Major Businesses
Table 128. Actavis (Allergan) Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 129. Actavis (Allergan) Testosterone Hormone Drug Product
Table 130. Actavis (Allergan) Recent Developments
Table 131. Bayer Corporation Information
Table 132. Bayer Description and Major Businesses
Table 133. Bayer Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 134. Bayer Testosterone Hormone Drug Product
Table 135. Bayer Recent Developments
Table 136. Novartis Corporation Information
Table 137. Novartis Description and Major Businesses
Table 138. Novartis Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 139. Novartis Testosterone Hormone Drug Product
Table 140. Novartis Recent Developments
Table 141. Teva Corporation Information
Table 142. Teva Description and Major Businesses
Table 143. Teva Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 144. Teva Testosterone Hormone Drug Product
Table 145. Teva Recent Developments
Table 146. Mylan Corporation Information
Table 147. Mylan Description and Major Businesses
Table 148. Mylan Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 149. Mylan Testosterone Hormone Drug Product
Table 150. Mylan Recent Developments
Table 151. Upsher-Smith Corporation Information
Table 152. Upsher-Smith Description and Major Businesses
Table 153. Upsher-Smith Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 154. Upsher-Smith Testosterone Hormone Drug Product
Table 155. Upsher-Smith Recent Developments
Table 156. Ferring Pharmaceuticals Corporation Information
Table 157. Ferring Pharmaceuticals Description and Major Businesses
Table 158. Ferring Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 159. Ferring Pharmaceuticals Testosterone Hormone Drug Product
Table 160. Ferring Pharmaceuticals Recent Developments
Table 161. Kyowa Kirin Corporation Information
Table 162. Kyowa Kirin Description and Major Businesses
Table 163. Kyowa Kirin Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 164. Kyowa Kirin Testosterone Hormone Drug Product
Table 165. Kyowa Kirin Recent Developments
Table 166. Acerus Pharmaceuticals Corporation Information
Table 167. Acerus Pharmaceuticals Description and Major Businesses
Table 168. Acerus Pharmaceuticals Testosterone Hormone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 169. Acerus Pharmaceuticals Testosterone Hormone Drug Product
Table 170. Acerus Pharmaceuticals Recent Developments
Table 171. Key Raw Materials Lists
Table 172. Raw Materials Key Suppliers Lists
Table 173. Testosterone Hormone Drug Distributors List
Table 174. Testosterone Hormone Drug Customers List
Table 175. Testosterone Hormone Drug Market Trends
Table 176. Testosterone Hormone Drug Market Drivers
Table 177. Testosterone Hormone Drug Market Challenges
Table 178. Testosterone Hormone Drug Market Restraints
Table 179. Research Programs/Design for This Report
Table 180. Key Data Information from Secondary Sources
Table 181. Key Data Information from Primary Sources
List of Figures
Figure 1. Testosterone Hormone Drug Product Picture
Figure 2. Global Testosterone Hormone Drug Market Share by Type in 2020 & 2027
Figure 3. Gels Product Picture
Figure 4. Injections Product Picture
Figure 5. Patches Product Picture
Figure 6. Global Testosterone Hormone Drug Market Share by Application in 2020 & 2027
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Others
Figure 10. Testosterone Hormone Drug Report Years Considered
Figure 11. Global Testosterone Hormone Drug Sales 2016-2027 (K Units)
Figure 12. Global Testosterone Hormone Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Testosterone Hormone Drug Revenue 2016-2027 (US$ Million)
Figure 14. Global Testosterone Hormone Drug Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 15. Global Testosterone Hormone Drug Sales Market Share by Region (2016-2021)
Figure 16. Global Testosterone Hormone Drug Sales Market Share by Region (2022-2027)
Figure 17. North America Testosterone Hormone Drug Sales YoY (2016-2027) & (K Units)
Figure 18. North America Testosterone Hormone Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 19. Europe Testosterone Hormone Drug Sales YoY (2016-2027) & (K Units)
Figure 20. Europe Testosterone Hormone Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 21. Asia-Pacific Testosterone Hormone Drug Sales YoY (2016-2027) & (K Units)
Figure 22. Asia-Pacific Testosterone Hormone Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 23. Latin America Testosterone Hormone Drug Sales YoY (2016-2027) & (K Units)
Figure 24. Latin America Testosterone Hormone Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 25. Middle East & Africa Testosterone Hormone Drug Sales YoY (2016-2027) & (K Units)
Figure 26. Middle East & Africa Testosterone Hormone Drug Revenue YoY (2016-2027) & (US$ Million)
Figure 27. The Top 10 and Top 5 Players Market Share by Testosterone Hormone Drug Sales in 2020
Figure 28. The Top 10 and Top 5 Players Market Share by Testosterone Hormone Drug Revenue in 2020
Figure 29. Testosterone Hormone Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 30. Global Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 31. Global Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 32. Global Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 33. Global Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 34. North America Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 35. North America Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 36. North America Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 37. North America Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 38. North America Testosterone Hormone Drug Sales Share by Country (2016-2027)
Figure 39. North America Testosterone Hormone Drug Revenue Share by Country (2016-2027)
Figure 40. United States Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 41. Canada Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 42. Europe Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 43. Europe Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 44. Europe Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 45. Europe Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 46. Europe Testosterone Hormone Drug Sales Share by Country (2016-2027)
Figure 47. Europe Testosterone Hormone Drug Revenue Share by Country (2016-2027)
Figure 48. Germany Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 49. France Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 50. U.K. Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 51. Italy Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 52. Russia Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 53. Asia Pacific Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 54. Asia Pacific Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 55. Asia Pacific Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 56. Asia Pacific Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 57. Asia Pacific Testosterone Hormone Drug Sales Share by Region (2016-2027)
Figure 58. Asia Pacific Testosterone Hormone Drug Revenue Share by Region (2016-2027)
Figure 59. China Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 60. Japan Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 61. South Korea Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 62. India Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 63. Australia Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 64. China Taiwan Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 65. Indonesia Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 66. Thailand Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 67. Malaysia Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 68. Latin America Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 69. Latin America Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 70. Latin America Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 71. Latin America Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 72. Latin America Testosterone Hormone Drug Sales Share by Country (2016-2027)
Figure 73. Latin America Testosterone Hormone Drug Revenue Share by Country (2016-2027)
Figure 74. Mexico Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 75. Brazil Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 76. Argentina Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Testosterone Hormone Drug Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Testosterone Hormone Drug Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Testosterone Hormone Drug Sales Market Share by Application (2016-2027)
Figure 80. Middle East and Africa Testosterone Hormone Drug Revenue Market Share by Application (2016-2027)
Figure 81. Middle East and Africa Testosterone Hormone Drug Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Testosterone Hormone Drug Revenue Share by Country (2016-2027)
Figure 83. Turkey Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Testosterone Hormone Drug Revenue (2016-2027) & (US$ Million)
Figure 86. Testosterone Hormone Drug Value Chain
Figure 87. Testosterone Hormone Drug Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

以下、関連資料のご紹介

世界の発根ホルモン粉末市場インサイト・予測（～2027年）

Global Rooting Hormone Powder Market Insights and Forecast to 2027
QY2108PAL0015 2021年8月 98Pages
本調査資料は発根ホルモン粉末の世界市場の現状について調査・分析し、2027年までの市場を予測しました。発根ホルモン粉末の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（作用剤、パウダー）、用途別市場規模（野菜根、果樹根）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・...

ホルモン補充療法の世界市場 2020年

Global Hormone Replacement Therapeutics Market 2020 by Company, Regions, Type and Application, Forecast to 2025
GIR201115597 2020年10月 124Pages
本書では、ホルモン補充療法の世界市場を調査対象にし、ホルモン補充療法の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン）、用途別分...

ホルモン補充治療の世界及び中国市場

Global and China Hormone Replacement Therapy Market Insights, Forecast to 2027
QY2108PAL8849 2021年6月 159Pages
QYResearch社発行の当調査資料ではグローバルにおけるホルモン補充治療の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、ホルモン補充治療の種類別市場規模（エストロゲンホルモン、成長ホルモン、甲状腺ホルモン、テストステロンホルモン）、用...

世界のJAK阻害薬市場インサイト・予測（～2027年）

Global JAK inhibitor Drug Market Insights and Forecast to 2027
QY2108PAL3982 2021年8月 86Pages
本調査資料はJAK阻害薬の世界市場の現状について調査・分析し、2027年までの市場を予測しました。JAK阻害薬の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（トファシチニブ、ルキソリチニブ、バリシチニブ）、用途別市場規模（関節リウマチ（RA）、真性多血症（PCV）、骨髄線維症（MF...

世界のJAK阻害薬市場インサイト・予測（～2027年）

テストステロン補充療法の世界市場 2020年

Global Testosterone Replacement Therapy Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201109561 2020年10月20日 104Pages
本書では、テストステロン補充療法の世界市場を調査対象にし、テストステロン補充療法の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ジェル、注射、パッチ、その他）、用途別分析（病院、クリニッ...

世界のJAK阻害剤ベース抗がん剤市場インサイト・予測（～2027年）

Global JAK Inhibitor Based Cancer Drug Market Insights and Forecast to 2027
QY2108PAL3981 2021年8月 89Pages
本調査資料はJAK阻害剤ベース抗がん剤の世界市場の現状について調査・分析し、2027年までの市場を予測しました。JAK阻害剤ベース抗がん剤の世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（トファシチニブ、ルキソリチニブ、バリシチニブ）、用途別市場規模（関節リウマチ（RA）、真性多血症...

世界のJAK阻害剤ベース抗がん剤市場インサイト・予測（～2027年）

成長ホルモン抑制ホルモンの世界市場 2020年

Global Growth Hormone-inhibiting Hormone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
GIR201111547 2020年10月20日 101Pages
本書では、成長ホルモン抑制ホルモンの世界市場を調査対象にし、成長ホルモン抑制ホルモンの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（オクトレオチド、ランレオチド、パシレオチド、その他）、...

世界の薬剤溶出カテーテル市場インサイト・予測（～2027年）

Global Drug Eluting Catheter Market Insights and Forecast to 2027
QY2108PAL3840 2021年8月 100Pages
本調査資料は薬剤溶出カテーテルの世界市場の現状について調査・分析し、2027年までの市場を予測しました。薬剤溶出カテーテルの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（PTA、PTCA）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、...

テストステロン補充療法の世界市場 2020年 Market Overview The Testosterone Replacement Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain op…
ホルモン補充療法の世界市場 2020年 Market Overview The global Hormone Replacement Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hormone Repl…
ホルモン補充治療の世界及び中国市場 Hormone replacement therapy refers to the treatment of the patients with hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low. Market competition is intense. Eli Lilly, Pfizer, AbbVie, Novo N…
成長ホルモン抑制ホルモンの世界市場 2020年 Market Overview The global Growth Hormone-inhibiting Hormone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Growth Horm…
世界の発根ホルモン粉末市場インサイト・予測（～2027年） Rooting Hormone Powder are auxin compounds belonging to the class of plant growth regulators and promoters, which are mainly suitable for raising seedlings, separating seedlings, transplanting and transplanting of cash crops such as fruits, vegetables, cotton, seedlings, flowers and medicinal materi…